Nanoparticles in Biotechnology and Pharmaceuticals Market Report – Research, Industry Analysis Reports and Market Demands

Global Nanoparticles in Biotechnology and Pharmaceuticals Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Nanoparticles in Biotechnology and Pharmaceuticals Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Fullerenes
- 1.4.3 Liquid Crystals
- 1.4.4 Liposomes
- 1.4.5 Nanoshells
- 1.4.6 Quantum dots
- 1.4.7 Superparamagnetic nanoparticles
1.5 Market by End User
- 1.5.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Biotechnology
- 1.5.3 Pharmaceutical
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size
- 2.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue 2014-2025
- 2.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales 2014-2025
2.2 Nanoparticles in Biotechnology and Pharmaceuticals Growth Rate by Regions
- 2.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Regions
- 2.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Nanoparticles in Biotechnology and Pharmaceuticals Sales by Manufacturers
- 3.1.1 Nanoparticles in Biotechnology and Pharmaceuticals Sales by Manufacturers
- 3.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Manufacturers
- 3.2.1 Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
3.3 Nanoparticles in Biotechnology and Pharmaceuticals Price by Manufacturers
3.4 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nanoparticles in Biotechnology and Pharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Nanoparticles in Biotechnology and Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Product
4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Product
4.3 Nanoparticles in Biotechnology and Pharmaceuticals Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Breakdown Data by End User

6 North America

6.1 North America Nanoparticles in Biotechnology and Pharmaceuticals by Countries
- 6.1.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries
- 6.1.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Nanoparticles in Biotechnology and Pharmaceuticals by Product
6.3 North America Nanoparticles in Biotechnology and Pharmaceuticals by End User

7 Europe

7.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals by Countries
- 7.1.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries
- 7.1.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals by Product
7.3 Europe Nanoparticles in Biotechnology and Pharmaceuticals by End User

8 Asia Pacific

8.1 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals by Countries
- 8.1.1 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals by Product
8.3 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals by End User

9 Central & South America

9.1 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals by Countries
- 9.1.1 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries
- 9.1.2 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals by Product
9.3 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals by End User

10 Middle East and Africa

10.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals by Countries
- 10.1.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals by Product
10.3 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals by End User

11 Company Profiles

12 Future Forecast

12.1 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Regions
- 12.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Forecast by Regions 2019-2025
12.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Product
- 12.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Forecast by Product 2019-2025
12.3 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by End User
12.4 North America Nanoparticles in Biotechnology and Pharmaceuticals Forecast
12.5 Europe Nanoparticles in Biotechnology and Pharmaceuticals Forecast
12.6 Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Forecast
12.7 Central & South America Nanoparticles in Biotechnology and Pharmaceuticals Forecast
12.8 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Nanoparticles in Biotechnology and Pharmaceuticals Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
The global Nanoparticles in Biotechnology and Pharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nanoparticles in Biotechnology and Pharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Nanoparticles in Biotechnology and Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nanoparticles in Biotechnology and Pharmaceuticals in these regions.
This research report categorizes the global Nanoparticles in Biotechnology and Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Nanoparticles in Biotechnology and Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire

Market size by Product
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles
Market size by End User
Biotechnology
Pharmaceutical

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Nanoparticles in Biotechnology and Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nanoparticles in Biotechnology and Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nanoparticles in Biotechnology and Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nanoparticles in Biotechnology and Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nanoparticles in Biotechnology and Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nanoparticles in Biotechnology and Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.